205 related articles for article (PubMed ID: 25085116)
1. Microporous polysaccharide hemosphere absorbable hemostat use in cardiothoracic surgical procedures.
Bruckner BA; Blau LN; Rodriguez L; Suarez EE; Ngo UQ; Reardon MJ; Loebe M
J Cardiothorac Surg; 2014 Aug; 9():134. PubMed ID: 25085116
[TBL] [Abstract][Full Text] [Related]
2. A Prospective Analysis of the Effects of a Powder-Type Hemostatic Agent on the Short-Term Outcomes after Liver Resection.
Kang M; Cho JY; Han HS; Yoon YS; Lee HW; Lee B; Park Y; Kim J
Medicina (Kaunas); 2024 Feb; 60(2):. PubMed ID: 38399565
[No Abstract] [Full Text] [Related]
3. Evaluation of the Safety and Efficacy of a Novel Thrombin Containing Combination Hemostatic Powder Using a Historical Control.
Bruckner BA; Spotnitz WD; Suarez E; Loebe M; Ngo U; Gillen DL; Manson RJ
Clin Appl Thromb Hemost; 2021; 27():10760296211017238. PubMed ID: 34024165
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Absorbable Hemostatic Powder for Prevention of Lymphoceles Following Robotic Prostatectomy With Lymphadenectomy.
Gilbert DR; Angell J; Abaza R
Urology; 2016 Dec; 98():75-80. PubMed ID: 27592524
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of hemostatic matrix and microporous polysaccharide hemospheres.
Lewis KM; Atlee H; Mannone A; Lin L; Goppelt A
J Surg Res; 2015 Feb; 193(2):825-30. PubMed ID: 25266604
[TBL] [Abstract][Full Text] [Related]
6. A Novel Hemostatic Patch That Stops Bleeding in Cardiovascular and Peripheral Vascular Procedures.
Howk K; Fortier J; Poston R
Ann Vasc Surg; 2016 Feb; 31():186-95. PubMed ID: 26597233
[TBL] [Abstract][Full Text] [Related]
7. The use fibrinogen/thrombin-coated equine collagen patch in children requiring reoperations for congenital heart disease. A single center clinical experience.
Vida VL; De Franceschi M; Barzon E; Padalino MA; Scattolin F; Stellin G
J Cardiovasc Surg (Torino); 2014 Jun; 55(3):401-6. PubMed ID: 24755705
[TBL] [Abstract][Full Text] [Related]
8. Microporous Polysaccharide Hemospheres (MPH) for cerebral hemostasis: a preliminary report.
Galarza M; Porcar OP; Gazzeri R; Martínez-Lage JF
World Neurosurg; 2011; 75(3-4):491-4. PubMed ID: 21600502
[TBL] [Abstract][Full Text] [Related]
9. Managing port-site bleeding during less invasive coronary artery bypass grafting.
Kiani S; Brecht ML; Lovinger K; Poston RS
Heart Surg Forum; 2012 Oct; 15(5):E272-6. PubMed ID: 23092664
[TBL] [Abstract][Full Text] [Related]
10. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
11. Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery.
Nasso G; Piancone F; Bonifazi R; Romano V; Visicchio G; De Filippo CM; Impiombato B; Fiore F; Bartolomucci F; Alessandrini F; Speziale G
Ann Thorac Surg; 2009 Nov; 88(5):1520-6. PubMed ID: 19853105
[TBL] [Abstract][Full Text] [Related]
12. Hemostatic efficacy of a flowable collagen-thrombin matrix during coronary artery bypass grafting: a double-blind randomized controlled trial.
Kim HH; Lee KJ; Kang DR; Lee JH; Youn YN
J Cardiothorac Surg; 2023 Jun; 18(1):193. PubMed ID: 37322537
[TBL] [Abstract][Full Text] [Related]
13. Improvement of Perioperative Outcomes in Major Gynecological and Gynecologic-Oncological Surgery with Hemostatic Gelatin-Thrombin Matrix.
Watrowski R; Jäger C; Forster J
In Vivo; 2017; 31(2):251-258. PubMed ID: 28358708
[TBL] [Abstract][Full Text] [Related]
14. A prospective, randomized, controlled trial of the efficacy and safety of fibrin pad as an adjunct to control soft tissue bleeding during abdominal, retroperitoneal, pelvic, and thoracic surgery.
Fischer CP; Bochicchio G; Shen J; Patel B; Batiller J; Hart JC
J Am Coll Surg; 2013 Sep; 217(3):385-93. PubMed ID: 23969113
[TBL] [Abstract][Full Text] [Related]
15. Hemostatic Efficacy and Biocompatibility Evaluation of a Novel Absorbable Porous Starch Hemostat.
Zhu J; Wu Z; Sun W; Meng Z; Zhu X; Gan H; Gu R; Guo X; Dou G
Surg Innov; 2022 Jun; 29(3):367-377. PubMed ID: 34551638
[TBL] [Abstract][Full Text] [Related]
16. The FINISH-3 trial: a phase 3, international, randomized, single-blind, controlled trial of topical fibrocaps in intraoperative surgical hemostasis.
Bochicchio GV; Gupta N; Porte RJ; Renkens KL; Pattyn P; Topal B; Troisi RI; Muir W; Chetter I; Gillen DL; Zuckerman LA; Frohna PA
J Am Coll Surg; 2015 Jan; 220(1):70-81. PubMed ID: 25458801
[TBL] [Abstract][Full Text] [Related]
17. Pre-emptive intraoperative administration of PCC4 in cardiac surgery patients at high risk of bleeding: A pilot study.
Elder J; McComb J; Lirette S; Herndon B; Yancey G; Mohammed A; Copeland H
J Card Surg; 2022 Dec; 37(12):5130-5134. PubMed ID: 36423240
[TBL] [Abstract][Full Text] [Related]
18. Comparison of a new fibrin sealant with standard topical hemostatic agents.
Schwartz M; Madariaga J; Hirose R; Shaver TR; Sher L; Chari R; Colonna JO; Heaton N; Mirza D; Adams R; Rees M; Lloyd D
Arch Surg; 2004 Nov; 139(11):1148-54. PubMed ID: 15545559
[TBL] [Abstract][Full Text] [Related]
19. Combination use of platelets and recombinant activated factor VII for increased hemostasis during acute type a dissection operations.
Yan W; Xuan C; Ma G; Zhang L; Dong N; Wang Z; Xu R
J Cardiothorac Surg; 2014 Sep; 9():156. PubMed ID: 25179738
[TBL] [Abstract][Full Text] [Related]
20. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy.
Mathiasen RA; Cruz RM
Otolaryngol Head Neck Surg; 2004 Nov; 131(5):601-5. PubMed ID: 15523433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
